The novel Chk1 inhibitor MK-8776 sensitizes human leukemia cells to HDAC inhibitors by targeting the intra-S checkpoint and DNA replication and repair (Q36927012)

From Wikidata
Jump to navigation Jump to search
scientific article published on 27 March 2013
edit
Language Label Description Also known as
English
The novel Chk1 inhibitor MK-8776 sensitizes human leukemia cells to HDAC inhibitors by targeting the intra-S checkpoint and DNA replication and repair
scientific article published on 27 March 2013

    Statements

    The novel Chk1 inhibitor MK-8776 sensitizes human leukemia cells to HDAC inhibitors by targeting the intra-S checkpoint and DNA replication and repair (English)
    Yun Dai
    Shuang Chen
    Maciej Kmieciak
    Liang Zhou
    Hui Lin
    Xin-Yan Pei
    Steven Grant
    27 March 2013
    878-889

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit